Additional file 1: of ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals

Huang, Chi-Ping; Chen, Jinbo; Chen, Chi-Cheng; Liu, Guodong; Zhang, Yong; Messing, Edward; Yeh, Shuyuan; Chang, Chawnshang

doi:10.6084/m9.figshare.8318807.v1

13046_2019_1258_MOESM1_ESM.pdf (84.71 kB)

Additional file 1: of ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-κB survival signals

journal contribution

posted on 2019-06-24, 05:00 authored by Chi-Ping Huang, Jinbo Chen, Chi-Cheng Chen, Guodong Liu, Yong Zhang, Edward Messing, Shuyuan Yeh, Chawnshang Chang

Figure S1. The illustration of xenografts and timeline of treatment regimen with Cisplatin (Cis) and ASC-J9® (ASC). Red arrows = ASC, black arrows = Cis. (PDF 84 kb)